U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820709) titled 'Artificial Intelligence for Staging Glaucoma Severity: A Comparison With an Eye Specialist Using Visual Field Tests' on July 14.
Brief Summary: The study titled "Reliability of Artificial Intelligence in Glaucoma Severity Staging Using the Brusini GSS2 System: A Longitudinal Comparative Study against Expert Assessment" aims to evaluate the diagnostic reliability and clinical utility of an Artificial Intelligence (AI) system in staging glaucoma severity using the Brusini Glaucoma Staging System 2 (GSS2) compared to expert ophthalmologist assessment.
The study protocol involves the longitudinal analysis of visual fields (VFs) collec...